ReShape Lifesciences reports Q3 results
RSLS Stock | USD 4.42 0.02 0.45% |
Slightly above 77 percent of ReShape Lifesciences' private investors are selling. The analysis of overall sentiment of trading ReShape Lifesciences stock suggests that a fairly large number of investors are terrified at this time. ReShape Lifesciences' investing sentiment can be driven by a variety of factors including economic data, ReShape Lifesciences' earnings reports, geopolitical events, and overall market trends.
ReShape |
ReShape Lifesciences reports a Q3 non-GAAP adjusted EBITDA loss of 2.9 million, compared to 4.2 million last year, and revenue of 2.16M, missing...
Read at seekingalpha.com
ReShape Lifesciences Investor Sentiment by Other News Outlets
Investor sentiment, mood or attitude towards ReShape Lifesciences can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
ReShape Lifesciences Fundamental Analysis
We analyze ReShape Lifesciences' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of ReShape Lifesciences using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of ReShape Lifesciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Book Value Per Share
Book Value Per Share Comparative Analysis
ReShape Lifesciences is currently under evaluation in book value per share category among its peers. Book Value per Share (B/S) can be calculated by subtracting liabilities from assets, and then dividing it by the total number of currently outstanding shares. It indicates the level of safety associated with each common share after removing the effects of liabilities. In other words, a shareholder can use this ratio to see how much he or she can sell the stake in the company in the event of a liquidation.
ReShape Lifesciences Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with ReShape Lifesciences stock to make a market-neutral strategy. Peer analysis of ReShape Lifesciences could also be used in its relative valuation, which is a method of valuing ReShape Lifesciences by comparing valuation metrics with similar companies.
Peers
ReShape Lifesciences Related Equities
HSDT | Helius Medical | 89.58 | ||||
HSCS | Heart Test | 11.99 | ||||
TIVC | Tivic Health | 5.00 | ||||
NURO | NeuroMetrix | 1.56 | ||||
NUWE | Nuwellis | 0.99 | ||||
BBLG | Bone Biologics | 3.81 | ||||
SINT | SINTX Technologies | 3.83 | ||||
TNON | Tenon Medical | 4.17 | ||||
IINN | Inspira Technologies | 4.30 |
Additional Tools for ReShape Stock Analysis
When running ReShape Lifesciences' price analysis, check to measure ReShape Lifesciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ReShape Lifesciences is operating at the current time. Most of ReShape Lifesciences' value examination focuses on studying past and present price action to predict the probability of ReShape Lifesciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ReShape Lifesciences' price. Additionally, you may evaluate how the addition of ReShape Lifesciences to your portfolios can decrease your overall portfolio volatility.